首页> 外文期刊>Biological & pharmaceutical bulletin >Pharmacokinetic study of triptolide, a constituent of immunosuppressive chinese herb medicine, in rats.
【24h】

Pharmacokinetic study of triptolide, a constituent of immunosuppressive chinese herb medicine, in rats.

机译:雷公藤甲素(一种抑制免疫的中草药成分)在大鼠中的药代动力学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Triptolide is a potential anti-immune agent, and has shown multi-organic toxicity, however its toxic mechanism remained undiscovered. This paper aimed at characterizing the pharmacokinetic profiles of triptolide in rats to provide the clue to approach the toxic mechanism. The absorption, distribution, metabolism and excretion of triptolide were investigated in male Sprague-Dawley rats after single doses of oral and i.v. administration. After oral administration of 0.6, 1.2 and 2.4 mg/kg, the concentration of triptolide in plasma reached the maximum within 15 min, and declined rapidly with an elimination half-life from 16.81 to 21.70 min. The triptolide kinetics was fitted into one-compartment model after i.v. administration. Oral absolute bioavailability was 72.08% at the dose of 0.6 mg/kg. Triptolide was also rapidly distributed and eliminated in all selected tissues. Less than 1% triptolide of the dose was recovered from the bile, urine or feces as parent drug within 48 h. While triptolide could not be detected in tissues and plasma at 4 h post dose, rats in the group C (oral: 1.2 mg/kg) and D (oral: 2.4 mg/kg) showed obvious toxic response to triptolide and some of rats even died out. It was indicated that triptolide was metabolized extensively, eliminated rapidly, and also showed that the toxicity produced by the triptolide was lag behind the exposure concentration.
机译:雷公藤内酯醇是一种潜在的抗免疫剂,并已显示出多种有机毒性,但其毒性机理尚未发现。本文旨在表征雷公藤甲素在大鼠体内的药代动力学特征,以提供接近毒性机制的线索。单次口服和静脉内注射后,在雄性Sprague-Dawley大鼠中研究了雷公藤甲素的吸收,分布,代谢和排泄。行政。口服0.6、1.2和2.4 mg / kg后,血浆中雷公藤甲素的浓度在15分钟内达到最大值,并迅速下降,消除半衰期从16.81至21.70分钟。雷公藤内酯动力学在静脉内注射后被拟合到一室模型中。行政。在0.6 mg / kg的剂量下,口服绝对生物利用度为72.08%。雷公藤甲素也迅速分布并在所有选定的组织中消除。在48小时内从胆汁,尿液或粪便中回收了不到1%剂量的雷公藤甲素作为母体药物。服药后4 h在组织和血浆中未检出雷公藤甲素,但C组(口服:1.2 mg / kg)和D组(口服:2.4 mg / kg)的大鼠对雷公藤甲素表现出明显的毒性反应,有些大鼠甚至死了。表明雷公藤内酯醇被广泛代谢,迅速消除,并且表明雷公藤内酯醇产生的毒性落后于暴露浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号